Literature DB >> 31019755

Association between different sequences of vessel ligation during video-assisted thoracoscopic lobectomy and survival in patients with non-small cell lung cancer.

Huang-He He1, Jia-Xi He1, Zhe-Xue Hao1, Wei Wang1, Jian-Xing He1.   

Abstract

BACKGROUND: The aim of this retrospective study was to assess the influence of the sequence of pulmonary vessel ligation during video-assisted thoracoscopic lobectomy on long-term survival in patients with non-small cell lung cancer (NSCLC).
METHODS: This retrospective study included 60 patients treated surgically with lobectomy and standard lymphadenectomy between 2012 and 2013. Patients had primary ligation of the pulmonary vein or veins (PV group, 33 patients) or of the pulmonary artery or arteries (PA group, 27 patients). Patients were excluded if they had undergone pulmonary wedge resection before lobectomy. Subgroup and sensitivity analyses were also used to investigate the effect of clinical characteristics of interest on survival.
RESULTS: Median follow-up was 54.5 months. Baseline characteristics of the two groups were statistically comparable regarding gender, histology, type of resection, T stage, and overall stage (all P>0.05). Overall, 5-year survival reached 66.67% in the PV group and 44.44% in the PA group (P=0.084). There were no differences between two groups regarding overall survival (OS) (P=0.063, HR: 2.093; 95% CI: 0.960-4.564), disease-free survival (DFS) (P=0.180, HR: 1.539; 95% CI: 0.820-2.889), or cancer-specific deaths (P=0.227, 14/33 vs. 17/27). Subgroup analyses showed no significant difference of OS (P=0.374, HR: 1.541; 95% CI: 0.594-3.997) or DFS (PLog-rank=0.746) for isolated adenocarcinoma, but significant differences in OS (PLog-Rank=0.036; HR: 3.992; 95% CI: 0.987-16.139) and DFS (P=0.044, HR: 3.011; 95% CI: 1.031-8.795) between the two groups of patients in whom squamous cell carcinomas. Sensitivity analysis showed that the differences were not statistically significant between the two groups regarding OS (P=0.140, HR: 1.944; 95% CI: 0.804-4.700) and DFS (P=0.190, HR: 1.605; 95% CI: 0.791-3.255) for patients with a tumour diameter of greater than 3 cm.
CONCLUSIONS: In summary, the sequence of pulmonary vessel ligation during video-assisted thoracoscopic lobectomy for NSCLC has no different effects on long-term survival, but for patients with squamous cell carcinoma, venous ligation should be preferred first since it may bring survival advantage after surgery.

Entities:  

Keywords:  Non-small cell lung cancer (NSCLC); lobectomy; pulmonary artery (PA); pulmonary vein (PV); survival

Year:  2019        PMID: 31019755      PMCID: PMC6462727          DOI: 10.21037/jtd.2019.02.69

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  20 in total

1.  Indications for lobectomy in the treatment of carcinoma of the lung.

Authors:  J C JONES; B W MEYER; J L ROBINSON
Journal:  J Thorac Surg       Date:  1956-10

2.  Observation of circulating tumour cells in patients with non-small cell lung cancer by real-time fluorescent quantitative reverse transcriptase-polymerase chain reaction in peroperative period.

Authors:  Ming Jian Ge; De Shi; Qing Chen Wu; Mei Wang; Liang Bin Li
Journal:  J Cancer Res Clin Oncol       Date:  2005-12-01       Impact factor: 4.553

3.  Inflow and outflow occlusion technique of the pulmonary artery and veins for the technically difficult left upper lobectomy.

Authors:  Douglas J Minnich; Ayesha S Bryant; David H Ashley; Robert J Cerfolio
Journal:  Eur J Cardiothorac Surg       Date:  2011-12-12       Impact factor: 4.191

Review 4.  Long-term survival in video-assisted thoracoscopic lobectomy vs open lobectomy in lung-cancer patients: a meta-analysis.

Authors:  Emanuela Taioli; Dong-Seok Lee; Martin Lesser; Raja Flores
Journal:  Eur J Cardiothorac Surg       Date:  2013-02-14       Impact factor: 4.191

5.  The sequence of vessel interruption during lobectomy: does it affect the amount of blood retained in the lobe?

Authors:  Alon Yellin; Siegal Sadetzki; David A Simansky; Yael Refaely; Angela Chetrit; Michael Paley
Journal:  Eur J Cardiothorac Surg       Date:  2007-02-15       Impact factor: 4.191

6.  The sequence of vessel interruption during lobectomy for non-small cell lung cancer: is it indeed important?

Authors:  Yael Refaely; Siegal Sadetzki; Angela Chetrit; David A Simansky; Michael Paley; Baruch Modan; Alon Yellin
Journal:  J Thorac Cardiovasc Surg       Date:  2003-06       Impact factor: 5.209

7.  [Expression of pin1 mRNA in the circulation of non-small cell lung cancer patients and influence of sequence of vessel ligation].

Authors:  Zheng-Hua Ai; Wei-Xing Zhang
Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban       Date:  2008-12

8.  The impact of the sequence of pulmonary vessel ligation during anatomic resection for lung cancer on long-term survival--a prospective randomized trial.

Authors:  A Kozak; J Alchimowicz; K Safranow; J Wójcik; L Kochanowski; B Kubisa; J Pieróg; T Grodzki
Journal:  Adv Med Sci       Date:  2013       Impact factor: 3.287

Review 9.  Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.

Authors:  Paul A Bunn
Journal:  Clin Lung Cancer       Date:  2004-09       Impact factor: 4.785

10.  Effects of different sequences of pulmonary artery and vein ligations during pulmonary lobectomy on blood micrometastasis of non-small cell lung cancer.

Authors:  Ping-Ping Song; Weidi Zhang; Baijiang Zhang; Qi Liu; Jiajun DU
Journal:  Oncol Lett       Date:  2012-11-09       Impact factor: 2.967

View more
  3 in total

1.  Vein-first Lobectomy for Lung Cancer Assessed According to the Status of Clustered Circulating Tumour Cells.

Authors:  Noriyoshi Sawabata; Shigeru Nakane; Daiki Yoshikawa; Takashi Watanabe; Takeshi Kawaguchi; Noriko Ouji-Sageshima; Keiji Kushibe; Toshihiro Ito
Journal:  Cancer Diagn Progn       Date:  2021-11-03

2.  Wedge Resection of Tumor Before Lobectomy for Lung Cancer Could Be a No-touch Isolation Technique.

Authors:  Motoaki Yasukawa; Noriyoshi Sawabata; Takeshi Kawaguchi; Shigeki Taniguchi
Journal:  In Vivo       Date:  2020 Mar-Apr       Impact factor: 2.155

Review 3.  Circulating Tumor Cells and the Non-Touch Isolation Technique in Surgery for Non-Small-Cell Lung Cancer.

Authors:  Hiroyuki Adachi; Hiroyuki Ito; Noriyoshi Sawabata
Journal:  Cancers (Basel)       Date:  2022-03-11       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.